08/26/2014 - 10:51am

A new report is shining a light on a key role pharmacists can play in helping patients understand the medicine they’re taking.

 

08/26/2014 - 10:45am

Fera Pharmaceuticals on Monday announced that it was selected by Pragma Pharmaceuticals to launch amoxicillin extended-release tablets

08/25/2014 - 10:05am

With the National Association of Chain Drug Stores Total Store Expo currently underway in Boston, the Boston Globe published an op-ed in its opinion section, Podium, which was co-authored by Steven Anderson, president and CEO of NACDS and Michael Malloy, PharmD and dean of the MCPHS University School of Pharmacy - Worcester/Manchester.

08/22/2014 - 11:11am

Mylan on Friday announced the launch of potassium chloride extended-release tablets USP in 600-mg and 750-mg dosage strengths.

08/22/2014 - 9:27am

The Drug Enforcement Administration issued a final rule rescheduling hydrocodone combination products from schedule III to schedule II of the Controlled Substances Act.

08/21/2014 - 10:59am

Restricting access to samples of generic biological drugs would lead to nearly $140 million in lost savings for every $1 billion in biologics sales, Matrix Global Advisors said.

08/21/2014 - 10:56am

The generic drug industry — and by extension, patients across the United States — is being adversely impacted by what some are calling branded drug makers’ abuse of risk evaluation and mitigation strategies, or REMS.

08/20/2014 - 6:42pm

Despite creating a detailed plan to speed up the rate at which generic drug applications are reviewed, experts say a backlog has developed at the Food and Drug Administration’s Office of Generic Drugs.

08/19/2014 - 1:02pm

The Food and Drug Administration has approved Mylan Institutional’s application for its dexmedetomidine hydrochloride injection, the company announced Tuesday.